ホーム › 骨髄増殖性腫瘍 › ニューヨーク › New York City
New York City、NYにおける骨髄増殖性腫瘍の臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、骨髄増殖性腫瘍に関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
被験者募集中第2相
- NYP/Weill Cornell Medical Center, New York
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Cord Blood Transplant in Adults With Blood Cancers
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
Project: Every Child for Younger Patients With Cancer
被験者募集中観察研究
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai Hospital, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- 他2件
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
被験者募集中第1相
- Icahn School of Medicine At Mount Sinai, New York
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
Asciminib Roll-over Study
被験者募集中第4相
- Memorial Sloan Kettering, New York
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
被験者募集中第1相
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
被験者募集中第2相
- Memorial Sloan Kettering, New York
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New York
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
被験者募集中第1相
- Columbia University, New York
他の都市における骨髄増殖性腫瘍の試験
- Houston, TX16件の研究
- Boston, MA14件の研究
- Miami, FL10件の研究
- Milwaukee, WI10件の研究
- Durham, NC9件の研究
- Baldwin Park, CA9件の研究
- Seattle, WA9件の研究
- Chicago, IL9件の研究
- Cleveland, OH8件の研究
- Portland, OR8件の研究
- Atlanta, GA8件の研究
- St. Louis, MO8件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。